These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15089810)

  • 1. Population pharmacokinetic modelling of Emfilermin (recombinant human leukaemia inhibitory factor, r-hLIF) in healthy postmenopausal women and in infertile patients undergoing in vitro fertilization and embryo transfer.
    Goggin T; Nguyen QT; Munafo A
    Br J Clin Pharmacol; 2004 May; 57(5):576-85. PubMed ID: 15089810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
    Zhou H; Mayer PR; Wajdula J; Fatenejad S
    J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study.
    Gholami H; Vicari E; Molis M; La Vignera S; Papaleo E; Cappiello F
    Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):97-102. PubMed ID: 20329567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].
    Yu R; Lin J; Zhao JZ; Wang PY; Xiao SQ; Zhang W
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):250-4. PubMed ID: 22781109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic model of human insulin following different routes of administration.
    Potocka E; Baughman RA; Derendorf H
    J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.
    Kappelhoff BS; Huitema AD; Crommentuyn KM; Mulder JW; Meenhorst PL; van Gorp EC; Mairuhu AT; Beijnen JH
    Br J Clin Pharmacol; 2005 Feb; 59(2):174-82. PubMed ID: 15676039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
    Bonate PL; Floret S; Bentzen C
    Br J Clin Pharmacol; 2004 Aug; 58(2):142-55. PubMed ID: 15255796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women.
    Karlsson MO; Wade JR; Loumaye E; Munafo A
    Br J Clin Pharmacol; 1998 Jan; 45(1):13-20. PubMed ID: 9489588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation and emergency in vitro fertilization for fertility preservation in cancer patients.
    Michaan N; Ben-David G; Ben-Yosef D; Almog B; Many A; Pauzner D; Lessing JB; Amit A; Azem F
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):175-7. PubMed ID: 20074845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of body mass index and age on the treatment of in vitro fertilization-embryo transfer among patients with non-polycystic ovarian syndrome].
    Chen H; Wang WJ; Chen YZ; Mai MQ; Ouyang NY; Chen JH; Tuo P
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 May; 31(5):567-71. PubMed ID: 21163039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of recombinant human leukemia inhibitory factor in sheep.
    Segrave AM; Mager DE; Charman SA; Edwards GA; Porter CJ
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1085-92. PubMed ID: 14872093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal estrogen supplementation in stimulated cycles may improve the pregnancy rate in patients undergoing in vitro fertilization/intracytoplasmic sperm injection-embryo transfer.
    Drakakis P; Loutradis D; Vomvolaki E; Stefanidis K; Kiapekou E; Anagnostou E; Anastasiadou K; Milingos S; Antsaklis A
    Gynecol Endocrinol; 2007 Nov; 23(11):645-52. PubMed ID: 17999276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
    Lukaszuk K; Liss J; Lukaszuk M; Maj B
    Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer.
    Dechaud H; Anahory T; Reyftmann L; Loup V; Hamamah S; Hedon B
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):88-93. PubMed ID: 16417960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atosiban improves implantation and pregnancy rates in patients with repeated implantation failure.
    Lan VT; Khang VN; Nhu GH; Tuong HM
    Reprod Biomed Online; 2012 Sep; 25(3):254-60. PubMed ID: 22818095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors related to occurrence of twin pregnancy after double-embryo transfer in vitro fertilization cycles].
    Niu ZH; Feng Y; Zhang AJ; Zhang HQ; Sun YJ; Lu XW
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jun; 44(6):413-7. PubMed ID: 19953939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors.
    Guo F; Letrent SP; Sharma A
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):799-809. PubMed ID: 17285315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
    Variol P; Nguyen L; Tranchand B; Puozzo C
    Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.